Cagrilintide + Semaglutide Blend
Subscriptions ship every 30 days. Cancel anytime from your account or the Track order page - no account needed.
- Discreet, tracked shipping with next business day dispatch.
- Supplied for in-vitro laboratory research only.
- Pay securely by card. Encrypted and discreet.
Description
Cagrilintide and semaglutide combined in one vial, an amylin and GLP-1 pairing studied in metabolic research.
- ReconstitutionCalculate dose and concentration ↓
Plan your reconstitution
See the concentration and syringe draw for this vial. Enter the bacteriostatic water you plan to add, and the amount you want to draw. For in-vitro research planning only.
Research planning arithmetic only. Not medical, dosing, or usage guidance. Open the full calculator with storage and FAQ
How to reconstitute a peptide vial, step by step →Certificate of analysis
No certificate of analysis has been published for this compound yet.
Cagrilintide + Semaglutide Blend questions
How is Cagrilintide + Semaglutide Blend shipped and packaged?
Orders ship in plain, unmarked packaging from within the US, fully tracked, and Cagrilintide + Semaglutide Blend is coming soon. When it arrives, orders dispatch the next business day once payment clears. Card payments are processed securely and show a neutral name on your statement. If a package is lost, held, damaged or wrong, our delivery guarantee reships or refunds it, no dispute needed.
How is Cagrilintide + Semaglutide Blend stored and reconstituted?
Cagrilintide + Semaglutide Blend is supplied lyophilized, generally kept frozen before reconstitution and refrigerated once in solution, within its stability window. Reconstitute with bacteriostatic water in a laboratory setting; our free reconstitution calculator works out the concentration and syringe draw for any vial size.
Still have a question about Cagrilintide + Semaglutide Blend? Email us and we reply within one business day. support@sjprimevitality.com
Related compounds
Held to the same sourcing and third-party testing standard.
